InspireMD, Inc. (NSPR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about InspireMD, Inc. (NSPR)
Go deeper and ask any question about NSPR
Company Performance
Current Price
as of Sep 13, 2024$2.72
P/E Ratio
N/A
Market Cap
$70.02M
Description
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Metrics
Overview
- HQTel Aviv, TA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNSPR
- Price$2.7237+0.88%
Trading Information
- Market Cap$70.02M
- Float74.47%
- Average Daily Volume (1m)9,915
- Average Daily Volume (3m)16,451
- EPS-$0.83
Company
- Revenue$6.57M
- Rev Growth (1yr)5.46%
- Net Income-$7.91M
- Gross Margin19.03%
- EBITDA Margin-471.19%
- EBITDA-$8.19M
- EV$43.69M
- EV/Revenue6.65
- P/EN/A
- P/S14.88
Documents
SEC Filings
Earnings Calls
Factset Street Account